Pfizer's Infliximab Biosimilar Approved In US But Won't Launch Against Inflectra

 
• By Sue Sutter
  
Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.
Pfizer's Ixifi is the first US approval of a biosimilar wholly developed by the big pharma.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip